Cite
HARVARD Citation
Rousselot, P. et al. (2021). Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients. British journal of haematology. pp. 393-402. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rousselot, P. et al. (2021). Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients. British journal of haematology. pp. 393-402. [Online].